End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.64 CNY | -0.26% | +8.06% | +13.86% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.86% | 5.23B | C | ||
-5.29% | 4.88B | C- | ||
+11.53% | 2.33B | - | - | |
+0.47% | 1.51B | B+ | ||
-7.03% | 1.37B | B | ||
-17.42% | 890M | - | D+ | |
-16.21% | 848M | - | ||
-8.79% | 583M | - | - | |
-38.14% | 377M | - | ||
-27.18% | 341M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 002064 Stock
- Ratings Huafon Chemical Co.,Ltd